Anti-Neurodegenerating Activity: Structure-Activity Relationship Analysis of Flavonoids

被引:2
作者
Preet, Gagan [1 ]
Hasan, Ahlam Haj [1 ,2 ]
Ramlagan, Piteesha [3 ]
Fawdar, Shameem [3 ]
Boulle, Fabien [3 ]
Jaspars, Marcel [1 ]
机构
[1] Univ Aberdeen, Marine Biodiscovery Ctr, Dept Chem, Aberdeen AB24 3UE, Scotland
[2] Jordan Univ Sci & Technol, Fac Pharm, Dept Med Chem & Pharmacognosy, Irbid 22110, Jordan
[3] Axonova Ltd, Grand Port 51405, Mauritius
来源
MOLECULES | 2023年 / 28卷 / 20期
关键词
flavones; flavonoids; SAR; neurodegeneration; computational; in silico; AMYLOID-INDUCED NEUROTOXICITY; NEURONAL SIGNAL-TRANSDUCTION; CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; O-METHYLATION; NADPH OXIDASE; BETA; QUERCETIN; ACETYLCHOLINESTERASE;
D O I
10.3390/molecules28207188
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
An anti-neurodegeneration activity study was carried out for 80 flavonoid compounds. The structure-activity analysis of the structures was carried out by performing three different anti-neurodegeneration screening tests, showing that in these structures, the presence of a hydroxy substituent group at position C3 ' as well as C5 ' of ring B and a methoxy substituent group at the C7 position of ring A play a vital role in neuroprotective and antioxidant as well as anti-inflammatory activity. Further, we found structure (5) was the top-performing active structure out of 80 structures. Subsequently, a molecular docking study was carried out for the 3 lead flavonoid compounds (4), (5), and (23) and 21 similar hypothetical proposed structures to estimate the binding strength between the tested compounds and proteins potentially involved in disease causation. Ligand-based pharmacophores were generated to guide future drug design studies.
引用
收藏
页数:21
相关论文
共 92 条
  • [1] Defects in trafficking bridge Parkinson's disease pathology and genetics
    Abeliovich, Asa
    Gitler, Aaron D.
    [J]. NATURE, 2016, 539 (7628) : 207 - 216
  • [2] Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease
    Alvarez, Anton
    Cacabelos, Ramon
    Sanpedro, Carolina
    Garcia-Fantini, Manuel
    Aleixandre, Manuel
    [J]. NEUROBIOLOGY OF AGING, 2007, 28 (04) : 533 - 536
  • [3] alz, Alzheimer's Disease Facts and Figures
  • [4] Alzheimer's Disease International, 2019, WORLD ALZH REP 2019, P100
  • [5] Flavonoids as lead compounds modulating the enzyme targets in Alzheimer's disease
    Anand, Preet
    Singh, Baldev
    [J]. MEDICINAL CHEMISTRY RESEARCH, 2013, 22 (07) : 3061 - 3075
  • [6] Focus on neurodegenerative disease
    不详
    [J]. NATURE NEUROSCIENCE, 2018, 21 (10) : 1293 - 1293
  • [7] [Anonymous], 2010, Drug Discov Today Technol, V7, pe203, DOI 10.1016/j.ddtec.2010.11.004
  • [8] [Anonymous], 2022, Molecular Operating Environment (MOE)
  • [9] Specificity in Trk receptor:neurotrophin interactions:: The crystal structure of TrkB-d5 in complex with neurotrophin-4/5
    Banfield, MJ
    Naylor, RL
    Robertson, AGS
    Allen, SJ
    Dawbarn, D
    Brady, RL
    [J]. STRUCTURE, 2001, 9 (12) : 1191 - 1199
  • [10] Literature Evidence and ARRIVE Assessment on Neuroprotective Effects of Flavonols in Neurodegenerative Diseases' Models
    Bombardi Duarte, Ana Carolina
    Santana, Maycon Giovani
    Orfali, Guilherme di Camilo
    Parisi de Oliveira, Carlos Tadeu
    Priolli, Denise Goncalves
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2018, 17 (01) : 34 - 42